Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
LONDON – U.S. rheumatoid arthritis patients had a significantly reduced incidence of type 2 diabetes when on treatment with either hydroxychloroquine or abatacept in an analysis of more than 13,000...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Abatacept | Arthritis | Diabetes | Diabetes Type 2 | Endocrinology | Hydroxychloroquine | Orencia | Rheumatoid Arthritis | Rheumatology